Stonepine Capital Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Stonepine Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.18 - $18.4 $819,866 - $1.48 Million	-80,537 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.51 - $11.72 $1.68 Million - $2.62 Million	-223,314 Reduced 73.49%	80,537 $839,000
Q2 2021 Aug 16, 2021	SELL	$8.69 - $11.08 $219,674 - $280,091	-25,279 Reduced 7.68%	303,851 $2.73 Million
Q1 2021 May 14, 2021	BUY	$8.89 - $14.92 $2.93 Million - $4.91 Million	329,130 New	329,130 $3.34 Million

163

58.2M

224K

1.41M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $390M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.